Vistin Pharma ASA: Invitation to Q1 2023 conference call
20 Aprile 2023 - 11:00AM
Vistin Pharma ASA: Invitation to Q1 2023 conference call
Oslo, Norway, 20 April 2023
Vistin Pharma ASA will release its first quarter 2023 results on
Thursday 27th of April 2023. Vistin Pharma will host a
conference call for all shareholders and interested parties at the
same day: Thursday 27th of April at 08:30 CET. There will be a
Q&A session following the management discussion.
The conference call will be held in English.
The first quarter conference call will be available via web and
audio through the following access points:
Webcast:
https://edge.media-server.com/mmc/p/esnqd8k9
Telephone conference
(online
registration):
https://register.vevent.com/register/BI27373abc81d0427486bb885a935c342c
*****
For further information, please contact:
Alexander KarlsenCFO+47 97053621alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing
Metformin Hydrochloride (API). The Metformin is also available as
Direct Compressible lubricated granules. As a solely dedicated
European Metformin producer, Vistin Pharma is a well-positioned
supplier to leading pharmaceutical companies. Vistin Pharma is
headquartered in Oslo, Norway, and has highly qualified employees
and a dedicated manufacturing facility in Kragerø.
Grafico Azioni Vistin Pharma Asa (LSE:0RAM)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Vistin Pharma Asa (LSE:0RAM)
Storico
Da Mag 2023 a Mag 2024